Kei-Lai Fong Selected Research

hematide

4/2010	Peri- and postnatal rodent development of Hematide, an erythropoiesis-stimulating agent.
1/2010	A subchronic murine intravenous pharmacokinetic and toxicity study of Hematide™, a PEGylated peptidic erythropoiesis-stimulating agent.
2/2009	Chronic pharmacological and safety evaluation of Hematide, a PEGylated peptidic erythropoiesis-stimulating agent, in rodents.
9/2008	Chronic preclinical safety evaluation of Hematide, a pegylated peptidic erythropoiesis stimulating agent in monkeys.
1/2008	Preclinical safety and pharmacology of Hematide, a peptidic erythropoiesis stimulating agent (ESA), in rats and monkeys.
10/2006	Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kei-Lai Fong Research Topics

Disease

6	Polycythemia (Erythrocytosis) 07/2011 - 01/2008
2	Chronic Renal Insufficiency 07/2011 - 10/2006
2	Anemia 09/2008 - 10/2006
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2011
1	Psoriatic Arthritis 12/2011
1	Hyperplasia 01/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2009
1	Neoplasms (Cancer) 10/2006

Drug/Important Bio-Agent (IBA)

6	hematideIBA 04/2010 - 10/2006
3	Peptides (Polypeptides)IBA 02/2009 - 10/2006
3	HematinicsIBA 02/2009 - 10/2006
1	apremilastIBA 12/2011
1	Hemoglobins (Hemoglobin)IBA 07/2011
1	peginesatideIBA 07/2011